Page last updated: 2024-08-22

camptothecin and Hormone-Dependent Neoplasms

camptothecin has been researched along with Hormone-Dependent Neoplasms in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (50.00)	18.2507
2000's	2 (33.33)	29.6817
2010's	1 (16.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, CS; Guh, JH; Ho, YF; Hsu, JL; Hsu, LC; Li, TK	1
Bigg, DC; Camara, J; Coulomb, H; Demarquay, D; Huchet, M; Kasprzyk, PG; Lavergne, O; Lesueur-Ginot, L; Prévost, G	1
Bonhoure, E; Calvet, C; Cuvillier, O; Doumerc, N; Garcia, V; Golzio, M; Malavaud, B; Mazerolles, C; Pchejetski, D; Rischmann, P; Teissié, J	1
Roth, BJ	1
Fan, S; Gupta, M; Kohn, KW; O'Connor, PM; Pommier, Y; Zhan, Q	1
Costa-Pereira, AP; Cotter, TG	1

Reviews

1 review(s) available for camptothecin and Hormone-Dependent Neoplasms

Article	Year
New therapeutic agents for hormone-refractory prostate cancer. Seminars in oncology, 1996, Volume: 23, Issue:6 Suppl 14 Topics: Antineoplastic Agents; Camptothecin; Clinical Trials as Topic; Estramustine; Humans; Male; Metalloendopeptidases; Neoplasms, Hormone-Dependent; Paclitaxel; Prostatic Neoplasms; Vinblastine; Vinorelbine	1996

Other Studies

5 other study(ies) available for camptothecin and Hormone-Dependent Neoplasms

Article	Year
Rottlerin potentiates camptothecin-induced cytotoxicity in human hormone refractory prostate cancers through increased formation and stabilization of topoisomerase I-DNA cleavage complexes in a PKCδ-independent pathway. Biochemical pharmacology, 2012, Jul-01, Volume: 84, Issue:1 Topics: Acetophenones; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzopyrans; Blotting, Western; Camptothecin; Cell Culture Techniques; Cell Line, Tumor; Cell Survival; DNA Cleavage; DNA Topoisomerases, Type I; Drug Synergism; Flow Cytometry; Humans; In Situ Nick-End Labeling; Male; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Protein Kinase C-delta; RNA, Small Interfering; Topoisomerase I Inhibitors; Transfection	2012
BN80927: a novel homocamptothecin that inhibits proliferation of human tumor cells in vitro and in vivo. Cancer research, 2004, Jul-15, Volume: 64, Issue:14 Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Camptothecin; Cell Division; Cell Line, Tumor; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; DNA, Superhelical; Drug Screening Assays, Antitumor; Drug Stability; Enzyme Inhibitors; HL-60 Cells; Humans; K562 Cells; Male; Mice; Mice, Nude; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Xenograft Model Antitumor Assays	2004
Sphingosine kinase-1 as a chemotherapy sensor in prostate adenocarcinoma cell and mouse models. Cancer research, 2005, Dec-15, Volume: 65, Issue:24 Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Camptothecin; Ceramides; Disease Models, Animal; Docetaxel; Flow Cytometry; Green Fluorescent Proteins; Humans; Lysophospholipids; Male; Mice; Mice, Nude; Microscopy, Fluorescence; Neoplasm Recurrence, Local; Neoplasms, Hormone-Dependent; Phosphotransferases (Alcohol Group Acceptor); Prostatic Neoplasms; RNA Interference; Sphingosine; Taxoids; Tumor Cells, Cultured	2005
Inactivation of p53 increases the cytotoxicity of camptothecin in human colon HCT116 and breast MCF-7 cancer cells. Clinical cancer research : an official journal of the American Association for Cancer Research, 1997, Volume: 3, Issue:9 Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Camptothecin; Colonic Neoplasms; DNA Damage; DNA Fragmentation; DNA, Neoplasm; Enzyme Inhibitors; Estrogens; Female; Flow Cytometry; G1 Phase; Genes, p53; Humans; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Nocodazole; Oncogene Proteins, Viral; Recombinant Fusion Proteins; Repressor Proteins; Topoisomerase I Inhibitors; Transfection; Tumor Cells, Cultured; Tumor Stem Cell Assay; Tumor Suppressor Protein p53	1997
Camptothecin sensitizes androgen-independent prostate cancer cells to anti-Fas-induced apoptosis. British journal of cancer, 1999, Volume: 80, Issue:3-4 Topics: Androgens; Antineoplastic Agents, Phytogenic; Apoptosis; Camptothecin; Caspases; Cytotoxicity, Immunologic; Enzyme Activation; Fas Ligand Protein; fas Receptor; Humans; Immunoglobulin M; Male; Membrane Glycoproteins; Mitochondria; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Reactive Oxygen Species; Tumor Cells, Cultured	1999